Serologic survey for control of hepatitis C in haemodialysis patients: Third-generation assays and analysis of costs

Nephrology Dialysis Transplantation

Volumn 12, Issue 2, 1997, Pages 298-303

  Fabrizi, F ^a,c   Lunghi, G ^b   Raffaele, L ^a   Guarnori, I ^a   Bacchini, G ^a   Corti, M ^a   Pagano, A ^b   Erba, G ^a   Locatelli, F ^a  

^a A MANZONI HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analysis of costs; Haemodialysis patients; Third generation HCV confirmatory assays; Third generation HCV screening assays

Indexed keywords

AMINOTRANSFERASE; HEPATITIS C ANTIBODY;

ADULT; AGED; ARTICLE; COST BENEFIT ANALYSIS; FEMALE; HEMODIALYSIS; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; COSTS AND COST ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0031046863     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.2.298     Document Type: Article

References (34)

1. Dentico P, Buogiorno R, Volpe A, Carlone A, Carbone M, Manno C, Proscia E, Pastore G, Schiraldi O. Prevalence and incidence of hepatitis C virus in hemodialysis patients: study of risk factors. Clin Nephrol 1992; 38: 49-52
2. Lin HH, Huang CC, Sheen IS, Lin DY, Liaw YF. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. Am J Nephrol 1991; 11: 192-194
3. Hardy NM, Sandroni S, Danielson S, Wilson WJ. Antibody to hepatitis C virus increases with time on hemodialysis. Clin Nephrol 1992; 38: 44-48
4. Jeffers LJ, Perez OG, de Medina MD, Ortiz-Interian CJ, Schiff ER, Reddy K, Jimenez M, Bourgoignie JJ, Vaamonde CA, Duncan R, Houghton M, Choo GL, Kuo G. Hepatitis C infection in two urban hemodialysis units. Kidney Int 1990; 38: 320-322
5. Zeldis JB, Depner TA, Kutamoto IK, Gish RG, Holland PV. The prevalence of hepatitis C virus among haemodialysis patients. Ann Intern Med 1990; 112: 958-960
6. Fabrizi F, Di Filippo S, Erba G, Bacchini G, Marcelli D, Pontoriero G, Crepaldi M, Locatelli F. Hepatitis C virus infection and hepatic function in chronic hemodialysis patients. Nephron 1992; 61: 119 (letter)
7. Gilli P, Moretti M, Soffritti S, Marchi N, Malacarne F, Bedani PL, De Paoli Vitali E, Fiocchi O, Menini C. Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients. Int J Artif Organs 1990; 13: 737-741
8. Oguchi H, Miyasaka M, Tokunaga S, Hora K, Ichikawa S, Ochi T, Yamada K, Nagasawa M, Kanno Y, Aizawa T, Watanabe H, Yoshizawa S, Sato K, Terashima M, Yoshie T, Oguchi S, Tanaka E, Kiyosawa K, Furuta S. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Clin Nephrol 1992; 38: 36-43
9. Mondelli MV, Cristina G, Piazza V, Cerino A, Villa G, Salvadeo A. High-prevalence of antibodies to hepatitis C virus in haemodialysis units using a second-generation assay. Nephron 1992; 61: 350-351
10. Fabrizi F, Bacchini G, Raffaele L, Erba G, Locatelli F. Anti-HCV antibodies and transaminase concentrations in hemodialysis patients: a study with second-generation assays. Nephrol Dial Transplant 1993; 8: 740-743
11. Carrera F, Silva JG, Pires C, Oliveira C. Prevalence of non-A, non-B hepatitis and anti-HCV antibodies in a Portuguese dialysis population. Nephrol Dial Transplant 1992; 7: 913-916
12. Carrera F, Silva JG, Oliveira C, Frazao JM, Pires C. Persistence of antibodies to hepatitis C virus in a chronic hemodialysis population. Nephron 1994; 68: 38-40
13. Silini E, Bono F, Cerino A, Piazza V, Solcia E, Mondelli VM. Virological features of hepatitis C virus infection in hemodialysis patients. J Clin Microbiol 1993; 31: 2913-2917
14. Sheu JC, Lee SH, Wang JT, Shih LN, Wang TH, Chen DS. Prevalence of anti-HCV and HCV viremia in hemodialysis patients in Taiwan. J Med Virol 1992; 37: 108-112
15. Sakamoto N, Enomoto N, Marumo F, Sato C. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. J Med Virol 1993; 39: 11-15
16. Chan TM, Lok ASF, Cheng IKP, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays. J Med Virol 1993; 17: 5-8
17. Muller GY, Zabaleta ME, Arminio A, Colmenares CJ, Capriles FI, Bianco NE, Machado IV. Risk factors for dialysis-associated hepatitis C in Venezuela. Kidney Int 1993; 41: 1055-1058
18. Hruby Z, Sliwinski J, Molin I, Zalewska M, Knysz B, Czyz W, Steciwko A, Bogucki J, Gladysz A. High prevalence of antibodies to hepatitis C virus in three hemodialysis centres in south-western Poland. Nephrol Dial Transplant 1993; 8: 740-743
19. Moyer AL, Alter MJ. Hepatitis C virus in the hemodialysis setting: a review with recommendations for control. Semin Dial 1994; 7: 124-127
20. Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Vox Sang 1994; 66: 122-129
21. Garcia-Samaniego J, Enriquez A, Soriano V, Gutierrez M, Baquero M, Munoz F. Third-generation recombinant immunoblot assay to confirm hepatitis C virus-indeterminate serological samples. Vox Sang 1993; 64: 191-192
22. Courouce AM, Bouchardeau F, Chaveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV RNA and anti-HCV antibodies (third-generation assays). Nephrol Dial Transplant 1995; 10: 234-239
23. Al Meshari K, Al Ahdal M, Alfurayh O, Ali A, De Vol E, Kessie G. New insights into hepatitis C virus infection of hemodialysis patients: the implications. Am J Kidney Dis 1995; 25: 572-578
24. van der Poel CL, Cuypers HT, Reesink HW, Weiner AJ, Quan S, di Nello R, van Boven JJ, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaarsbeerg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. Confirmation of hepatitis C virus infection by new four antigen recombinant immunoblot assay. Lancet 1991; 337: 317-319
25. Prati D, Capelli C, Bosoni P, Mozzi F, Zanella A, Sirchia G. Determination of hepatitis C virus RNA in the serum by the Amplicor HCV PCR kit. Vox Sang 1994; 67: 112-114
26. Fabrizi F, Lunghi G, Guarnori I, Raffaele L, Di Filippo S, Erba G, Pagano A, Locatelli F. Virological characteristics of hepatitis C virus infection in chronic haemodialysis patients: a cross-sectional study. Clin Nephrol 1995; 44: 49-55
27. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-585
28. Zaaijer HI, Cuypers HTM, Reesink HW, Winkel IN, Gerken G, Lelie PN. Reliability of polymerase chain reaction for detection of hepatitis C virus. Lancet 1993; 341: 722-724
29. Dow BC, Follett EAC, Jordan T, McOmish F, Davidson J, Gillon J, Yap PL, Simmonds P. Testing of blood donations for hepatitis C virus. Lancet 1994; 343: 477 (letter)
30. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 853 (letter) Courouce AM, Bouchardeau F, Girault F, LeMarrec N. Lancet 1994; 343: 853 (reply) Goffin E, Pirson Y, Cornu C, Jadoul M, van Ypersele de Strihou. Lancet 1994; 343: 854 (reply)
31. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 853 (letter) Courouce AM, Bouchardeau F, Girault F, LeMarrec N. Lancet 1994; 343: 853 (reply) Goffin E, Pirson Y, Cornu C, Jadoul M, van Ypersele de Strihou. Lancet 1994; 343: 854 (reply)
32. Vernelen K, Claeys H, Verhaert H, Volckaerts A, Vermylen C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994; 343: 853 (letter) Courouce AM, Bouchardeau F, Girault F, LeMarrec N. Lancet 1994; 343: 853 (reply) Goffin E, Pirson Y, Cornu C, Jadoul M, van Ypersele de Strihou. Lancet 1994; 343: 854 (reply)
33. Fabrizi F, Raffaele L, Guarnori I, Bacchini G, Erba GF, Locatelli F. Conflicting results of hepatitis C virus serological tests in haemodialysis patients. Nephron 1993; 64: 652 (letter)
34. Centers for Disease Control. Hepatitis-control measures for hepatitis B in dialysis centers. Atlanta, Centers for Disease Control, HEW Publication No. (CDC) 78-8358 (Viral Hepatitis Investigations and Control Series), 1977.